Iheoma Alinnor

Iheoma Alinnor practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Iheoma Alinnor's NPI, 1164927174, was assigned on March 30, 2018. Iheoma Alinnor holds Georgia license 88071.

Iheoma Alinnor's primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Iheoma Alinnor's primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. The medical group on file is Emory Healthcare.

Dmand AI tracks the electronic health record (EHR) system at each site where Iheoma Alinnor practices. Vendor and product names are available with a free account.

Internal medicine is Iheoma Alinnor's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Iheoma Alinnor is licensed in Georgia.

CMS data shows 193 Medicare services from Iheoma Alinnor across 5 procedure codes in 2024, for 72 Medicare patients. Medicare paid $15,598 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Iheoma Alinnor in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 68% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Iheoma Alinnor's median patient age at 70, with 48% women.

In 2024, Iheoma Alinnor wrote 402 Medicare Part D claims for 70 patients. 72% of them were for generic drugs. CMS names the drug for 117 of them, across 6 drugs with 11 or more claims each, at $33,246 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Iheoma Alinnor for performance year 2024, reported as part of a group. Iheoma Alinnor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Iheoma Alinnor in 2024. Iheoma Alinnor's most frequent co-authors are Lance T. Hall, MD and Stacey Michelle Watkins, MD, PhD.

CMS Open Payments shows 1 general payment to Iheoma Alinnor from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Alkermes, Inc. paid the most, $103.